Deciphera Pharmaceuticals Inc. (NASDAQ: DCPH) stock closed at 12.46 per share at the end of the most recent trading day (a -1.74% change compared to the prior day closing price) with a volume of 410.59K shares and market capitalization of 982.11M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 350 people. Deciphera Pharmaceuticals Inc. CEO is Steven L. Hoerter.

The one-year performance of Deciphera Pharmaceuticals Inc. stock is -33.4%, while year-to-date (YTD) performance is -23.98%. DCPH stock has a five-year performance of -60.01%. Its 52-week range is between 12.33 and 22.76, which gives DCPH stock a 52-week price range ratio of 1.25%

Deciphera Pharmaceuticals Inc. currently has a PE ratio of -6.20, a price-to-book (PB) ratio of 3.91, a price-to-sale (PS) ratio of 14.17, a price to cashflow ratio of -, a PEG ratio of -0.09, a ROA of -50.01%, a ROC of -55.03% and a ROE of -63.61%. The company’s profit margin is -%, its EBITDA margin is -181.10%, and its revenue ttm is $97.69 Million , which makes it $1.45 revenue per share.

Of the last four earnings reports from Deciphera Pharmaceuticals Inc., there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.60 for the next earnings report. Deciphera Pharmaceuticals Inc.’s next earnings report date is 02nd Nov 2023.

The consensus rating of Wall Street analysts for Deciphera Pharmaceuticals Inc. is Strong Buy (1.25), with a target price of $20.6, which is +65.33% compared to the current price. The earnings rating for Deciphera Pharmaceuticals Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Deciphera Pharmaceuticals Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Deciphera Pharmaceuticals Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 13.41, ATR14 : 0.48, CCI20 : -96.11, Chaikin Money Flow : -0.26, MACD : -0.40, Money Flow Index : 29.23, ROC : -8.72, RSI : 36.57, STOCH (14,3) : 7.18, STOCH RSI : 0.34, UO : 42.23, Williams %R : -92.82), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Deciphera Pharmaceuticals Inc. in the last 12-months were: Associates LLC. Brightstar (Buy at a value of $29 999 988), Associates LLC. Brightstar (Sold 0 shares of value $-24 277 ), Daniel C. Martin (Sold 4 000 shares of value $69 377 ), Daniel L. Flynn (Sold 3 773 shares of value $71 728 ), Daniel Lee Flynn (Sold 5 428 shares of value $95 559 ), Franklin Stuart Friedman (Buy at a value of $138 800), Jama Pitman (Sold 2 762 shares of value $51 550 ), Matthew L. Sherman (Sold 3 374 shares of value $65 704 ), Pitman Jama (Sold 4 000 shares of value $69 376 ), Sherman Matthew (Sold 5 029 shares of value $89 534 ), Steven L. Hoerter (Sold 67 590 shares of value $1 078 222 ), Thomas P. Kelly (Sold 3 773 shares of value $71 728 ), Thomas Patrick Kelly (Sold 5 428 shares of value $95 559 ), Walsh Dennis (Buy at a value of $152 460)